These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38928133)

  • 21. The effect of IL-5 and eotaxin expression in the lung on eosinophil trafficking and degranulation and the induction of bronchial hyperreactivity.
    Mould AW; Ramsay AJ; Matthaei KI; Young IG; Rothenberg ME; Foster PS
    J Immunol; 2000 Feb; 164(4):2142-50. PubMed ID: 10657668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression.
    Lei Q; Hou H; Yu C; Zhang Y; Ndzouboukou JB; Lin X; Yao Z; Fu H; Sun Z; Wang F; Fan X
    J Immunol Res; 2021; 2021():9822706. PubMed ID: 34712742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
    Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
    Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of clinical outcomes.
    Uranga-Murillo I; Morte E; Hidalgo S; Pesini C; García-Mulero S; Sierra JL; Santiago L; Arias M; De Miguel D; Encabo-Berzosa MDM; Gracia-Tello B; Sanz-Pamplona R; Martinez-Lostao L; Galvez EM; Paño-Pardo JR; Ramirez-Labrada A; Pardo J
    Theranostics; 2022; 12(1):290-306. PubMed ID: 34987646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.
    Kim CK; Kita H; Callaway Z; Kim HB; Choi J; Fujisawa T; Shin BM; Koh YY
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e697-704. PubMed ID: 20444156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine Signature Associated With Disease Severity in COVID-19.
    Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
    Front Immunol; 2021; 12():681516. PubMed ID: 34489933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulation of CCL11 and CCL26 is associated with activated eosinophils in bullous pemphigoid.
    Günther C; Wozel G; Meurer M; Pfeiffer C
    Clin Exp Immunol; 2011 Nov; 166(2):145-53. PubMed ID: 21985360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti.
    Jean-Baptiste S; O'Toole EA; Chen M; Guitart J; Paller A; Chan LS
    Clin Exp Immunol; 2002 Mar; 127(3):470-8. PubMed ID: 11966763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients.
    Penttilä PA; Van Gassen S; Panovska D; Vanderbeke L; Van Herck Y; Quintelier K; Emmaneel A; Filtjens J; Malengier-Devlies B; Ahmadzadeh K; Van Mol P; Borràs DM; Antoranz A; Bosisio FM; Wauters E; Martinod K; Matthys P; Saeys Y; Garg AD; Wauters J; De Smet F;
    Cell Mol Life Sci; 2021 Apr; 78(8):3987-4002. PubMed ID: 33715015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory and Autoimmune Aspects of Multisystem Inflammatory Syndrome in Children (MIS-C): A Prospective Cohort Study.
    Lawrence DA; Jadhav A; Mondal TK; Carson K; Lee WT; Hogan AH; Herbst KW; Michelow IC; Brimacombe M; Salazar JC; The Connecticut Children's Covid Collaborative
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological Characteristics in Type 2 Diabetes Mellitus Among COVID-19 Patients.
    Han M; Ma K; Wang X; Yan W; Wang H; You J; Wang Q; Chen H; Guo W; Chen T; Ning Q; Luo X
    Front Endocrinol (Lausanne); 2021; 12():596518. PubMed ID: 33776910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eotaxin but not MCP-3 induces eosinophil influx into nasal fluid in allergic patients.
    Górski P; Wittczak T; Walusiak J; Pałczyński C; Ruta U; Kuna P; Alam R
    Allergy; 2002 Jun; 57(6):519-28. PubMed ID: 12028117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinopenia <100/μL as a marker of active COVID-19: An observational prospective study.
    Outh R; Boutin C; Gueudet P; Suzuki M; Saada M; Aumaître H
    J Microbiol Immunol Infect; 2021 Feb; 54(1):61-68. PubMed ID: 33468435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
    Honda K; Chihara J
    Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of eosinophil β chain-signaling cytokines receptors, outer-membrane integrins, and type 2 inflammation biomarkers in severe non-allergic eosinophilic asthma.
    Kalinauskaite-Zukauske V; Januskevicius A; Janulaityte I; Miliauskas S; Malakauskas K
    BMC Pulm Med; 2019 Aug; 19(1):158. PubMed ID: 31438916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males.
    Fonseca W; Asai N; Yagi K; Malinczak CA; Savickas G; Johnson CC; Murray S; Zoratti EM; Lukacs NW; Li J; Schuler Iv CF
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
    Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
    J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.